Literature DB >> 33362760

Neutrophil Inflammatory Response Is Downregulated by Uptake of Superparamagnetic Iron Oxide Nanoparticle Therapeutics.

Gustavo Garcia1, Min-Ho Kim2, Vasilios Aris Morikis1, Scott I Simon1.   

Abstract

Superparamagnetic iron oxide nanoparticles (SPION) are employed as diagnostics and therapeutics following intravenous delivery for the treatment of iron deficiency anemia (IDA) in adult patients with chronic kidney failure. Neutrophils are the first defense against blood borne foreign insult and recruit to vascular sites of inflammation via a sequential process that is characterized by adhesive capture, rolling, and shear resistant arrest. A primary chemotactic agonist presented on the glycocalyx of inflamed endothelium is IL-8, which upon binding to its cognate membrane receptor (CXCR1/2) activates a suite of responses in neutrophils. An early response is degranulation with accompanying upregulation of β2-integrin (CD11/CD18) and shedding of L-selectin (CD62L) receptors, which exert differential effects on the efficiency of endothelial recruitment. Feraheme is an FDA approved SPION treatment for IDA, but its effect on the innate immune response of neutrophils during inflammation has not been reported. Here, we studied the immunomodulatory effects of Feraheme on neutrophils freshly isolated from healthy human subjects and stimulated in suspension or on inflammatory mimetic substrates with IL-8. Cells treated with Feraheme exhibited reduced sensitivity to stimulation with IL-8, indicated by reduced upregulation of membrane CD11b/CD18 receptors, high affinity (HA) CD18, and shedding of CD62L. Feraheme also inhibited N-formyl-Met-Leu-Phe (fMLP) induced reactive oxygen species production. Neutrophil rolling, arrest, and migration was assessed in vascular mimetic microfluidic channels coated with E-selectin and ICAM-1 to simulate inflamed endothelium. Neutrophils exposed to Feraheme rolled faster on E-selectin and arrested less frequently on ICAM-1, in a manner dependent upon SPION concentration. Subsequent neutrophil shape change, and migration were also significantly inhibited in the presence of Feraheme. Lastly, Feraheme accelerated clearance of cytosolic calcium flux following IL-8 stimulation. We conclude that uptake of Feraheme by neutrophils inhibits chemotactic activation and downregulates normal rolling to arrest under shear flow. The mechanism involves increased calcium clearance following chemotactic activation, which may diminish the efficiency of recruitment from the circulation at vascular sites of inflammation.
Copyright © 2020 Garcia, Kim, Morikis and Simon.

Entities:  

Keywords:  immunosupression; inflammation; innate immunity; iron oxide; mechanosignaling; nanoparticle; neutrophil degranulation; neutrophil recruitment

Mesh:

Substances:

Year:  2020        PMID: 33362760      PMCID: PMC7757401          DOI: 10.3389/fimmu.2020.571489

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  40 in total

1.  Accelerated resequestration of cytosolic calcium and suppression of the pro-inflammatory activities of human neutrophils by CGS 21680 in vitro.

Authors:  R Anderson; S S Visser; G Ramafi; A J Theron
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

2.  Vascular mimetics based on microfluidics for imaging the leukocyte--endothelial inflammatory response.

Authors:  Ulrich Y Schaff; Malcolm M Q Xing; Kathleen K Lin; Ning Pan; Noo Li Jeon; Scott I Simon
Journal:  Lab Chip       Date:  2007-01-23       Impact factor: 6.799

Review 3.  Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations.

Authors:  Ankit Shah; Marina A Dobrovolskaia
Journal:  Nanomedicine       Date:  2018-02-02       Impact factor: 5.307

Review 4.  Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.

Authors:  Daniel Bobo; Kye J Robinson; Jiaul Islam; Kristofer J Thurecht; Simon R Corrie
Journal:  Pharm Res       Date:  2016-06-14       Impact factor: 4.200

5.  Selectin catch-bonds mechanotransduce integrin activation and neutrophil arrest on inflamed endothelium under shear flow.

Authors:  Vasilios A Morikis; Shannon Chase; Ted Wun; Elliot L Chaikof; John L Magnani; Scott I Simon
Journal:  Blood       Date:  2017-08-15       Impact factor: 22.113

Review 6.  Neutrophil function: from mechanisms to disease.

Authors:  Borko Amulic; Christel Cazalet; Garret L Hayes; Kathleen D Metzler; Arturo Zychlinsky
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

7.  Interaction of polyacrylic acid coated and non-coated iron oxide nanoparticles with human neutrophils.

Authors:  Diana Couto; Marisa Freitas; Vânia Vilas-Boas; Irene Dias; Graça Porto; M Arturo Lopez-Quintela; José Rivas; Paulo Freitas; Félix Carvalho; Eduarda Fernandes
Journal:  Toxicol Lett       Date:  2013-11-26       Impact factor: 4.372

8.  Nanoparticle Uptake: The Phagocyte Problem.

Authors:  Heather Herd Gustafson; Dolly Holt-Casper; David W Grainger; Hamidreza Ghandehari
Journal:  Nano Today       Date:  2015-09-05       Impact factor: 20.722

9.  Neutrophil-mediated transport is crucial for delivery of short-circulating magnetic nanoparticles to tumors.

Authors:  Victor Naumenko; Aleksey Nikitin; Anastasiia Garanina; Pavel Melnikov; Stepan Vodopyanov; Ksenia Kapitanova; Daria Potashnikova; Daniil Vishnevskiy; Irina Alieva; Artem Ilyasov; Barbara Z Eletskaya; Maxim Abakumov; Vladimir Chekhonin; Alexander Majouga
Journal:  Acta Biomater       Date:  2020-01-13       Impact factor: 8.947

10.  Gold nanoparticles induce apoptosis, endoplasmic reticulum stress events and cleavage of cytoskeletal proteins in human neutrophils.

Authors:  Claudie Noël; Jean-Christophe Simard; Denis Girard
Journal:  Toxicol In Vitro       Date:  2015-11-07       Impact factor: 3.500

View more
  1 in total

Review 1.  Nanoparticles in the diagnosis and treatment of vascular aging and related diseases.

Authors:  Hui Xu; Shuang Li; You-Shuo Liu
Journal:  Signal Transduct Target Ther       Date:  2022-07-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.